ReviewChinese medical journal2026

Novel targeted therapy and cellular immunotherapy enabling allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute myeloid leukemia.

Liqin Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.